A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling. - Dolan M; Shi Y; Mastri M; Long MD; McKenery A; Hill JW; Vaghi C; Benzekry S; Barbi J; Ebos JML (Molecular cancer therapeutics, 2024)